facebook

Why No Surgeon Can Guarantee Perfect Vision After Refractive Surgery

5 min read

Why No Surgeon Can Guarantee Perfect Vision After Refractive Surgery

A guarantee of perfect vision is not a clinical statement. It is a commercial claim that is not legally or biologically supportable. The UK legal standard, established in Montgomery v Lanarkshire Health Board, requires something more demanding: honest, material disclosure.

The Legal Standard

Following Montgomery v Lanarkshire Health Board (2015), UK surgeons are required to disclose all material risks that a reasonable patient would consider significant. The test is not what the surgeon considers significant, it is what a reasonable patient, properly informed, would want to know before making their decision. ¹

A consultation that does not address the possibility of suboptimal outcomes, enhancement, persistent dry eye, or residual visual symptoms does not meet this standard, regardless of how positive the expected outcome is.

Why Biology Prevents Guarantees

Modern refractive platforms deliver highly precise ablations within manufacturer tolerance. What they cannot engineer is the corneal healing response. Keratocyte activity, epithelial remodelling, corneal biomechanics, and individual neural adaptation all influence the final refractive outcome in ways that are not fully predictable from preoperative data. ²

In practical terms: A guaranteed outcome in a biological system is a contradiction in terms. The cornea is not a computer. The ablation precision does not eliminate biological variability in what happens next.

What Honest Consent Includes at Blue Fin Vision®

Informed consent at Blue Fin Vision® is a documented clinical process. Patients receive:

  • Procedure-specific outcome probability ranges based on their refractive profile
  • Enhancement rate estimates relevant to their correction and procedure type
  • Disclosure of recognised risks: dry eye, corneal haze (for surface ablation), night vision changes, residual refractive error
  • An explanation of the enhancement policy and what it means if they are in the minority
  • Time to review documentation before confirming their decision

Patients who receive full, evidence-based disclosure of risks and realistic outcome ranges make more considered decisions and report higher satisfaction even when outcomes involve complexity. This is the consistent finding across the consent research literature. ³

What to Look For in a Consultation

If a consultation does not address what happens when things are not straightforward, if it presents only the positive trajectory, that omission is itself a clinical signal. It suggests either that no management protocol exists for suboptimal outcomes, or that the provider has chosen not to disclose it. Both are problems.

Blue Fin Vision® specifically: Blue Fin Vision® does not use financing or payment plans to facilitate elective surgery decisions. This is a clinical position: patients who fund elective surgery with credit are under a financial structure that may compromise their ability to exercise genuine consent. The practice is explicit about this at consultation.

When things are straightforward, many clinics perform well. When they are not, that is where systems, experience and accountability matter most.

Frequently Asked Questions

Is it a red flag if a clinic guarantees perfect vision?

Yes. No surgeon can lawfully guarantee a specific visual outcome in a biological system. A guarantee of perfect vision is not clinically supportable and should prompt the patient to ask what the clinic does when that guarantee cannot be delivered. The more appropriate framing is: what is the probability of achieving the intended correction, and what is the management plan if you do not?

What is the Montgomery standard and how does it apply to me?

Montgomery v Lanarkshire Health Board (2015) established that informed consent in the UK requires disclosure of all material risks that a reasonable patient in the patient’s position would want to know. For refractive surgery, this means your surgeon must disclose enhancement rates, recognised complications, and what happens if the outcome is not as intended, before you agree to proceed.

How do I know if my consent process was adequate?

Your consent process should have included a written document listing specific risks, a discussion of outcome probability ranges relevant to your prescription, and an explanation of what happens if your result requires further treatment. If you had a 10-minute consultation followed by a booking form, the consent process was not adequate by the Montgomery standard.

References

  1. Montgomery v Lanarkshire Health Board UKSC 11. Supreme Court of the United Kingdom; 2015.
  2. Dupps WJ Jr, Wilson SE. Biomechanics and wound healing in the cornea. Exp Eye Res. 2006;83(4):709-720.
  3. Coulter A, Entwistle VA, Eccles A, Ryan S, Shepperd S, Perera R. Personalised care planning for adults with chronic or long-term health conditions. Cochrane Database Syst Rev. 2015;(3):CD010523.
  4. Trevino R, Parikh JG. The evolution of the standard of care and informed consent in refractive surgery. Curr Opin Ophthalmol. 2013;24(4):300-304.
  5. Stulting RD, Carr JD, Thompson KP, Waring GO, Wiley WM, Walker JG. Complications of laser in situ keratomileusis for the correction of myopia. Ophthalmology. 1999;106(1):13-20.

Related Topics

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.